HOME >> MEDICINE >> NEWS
Hybrid molecule causes cancer cells to self-destruct

By joining a sugar to a short-chain fatty acid compound, Johns Hopkins researchers have developed a two-pronged molecular weapon that kills cancer cells in lab tests. The researchers cautioned that their double-punch molecule, described in the December issue of the journal Chemistry & Biology, has not yet been tested on animals or humans. Nevertheless, they believe it represents a promising new strategy for fighting the deadly disease.

"For a long time, cancer researchers did not pay much attention to the use of sugars in fighting cancer," said Gopalan Sampathkumar, a postdoctoral fellow in the university's Department of Biomedical Engineering and lead author of the journal article. "But we found that when the right sugar is matched with the right chemical partner, it can deliver a powerful double-whammy against cancer cells."

Sampathkumar and his colleagues built upon 20-year-old findings that a short-chain fatty acid called butyrate can slow the spread of cancer cells. In the 1980s, researchers discovered that butyrate, which is formed naturally at high levels in the digestive system by symbiotic bacteria that feed on fiber, can restore healthy cell functioning.

Efforts to use butyrate as a general drug for tumors elsewhere in the body, however, have been hindered by the high doses of the compound needed to effectively eradicate cancer. To get around this problem, scientists have tried to make butyrate more potent by modifying it or joining it to other compounds. Usually, the results have been disappointing because the molecular partner added to butyrate to improve delivery to the cancer cells often produced unsafe side effects.

In some of the less successful experiments, designed to avoid toxic side effects, researchers used innocuous sugar molecules such as glucose to carry butyrate into the cells. The Johns Hopkins team tried a different tack. "We didn't think they chose the right partner molecule," said Kevin J. Ya
'"/>

Contact: Phil Sneiderman
prs@jhu.edu
443-287-9960
Johns Hopkins University
3-Jan-2007


Page: 1 2 3

Related medicine news :

1. Scientists from the CIMA investigate a molecule for diagnosing hypertensive cardiopathy
2. Electric jolt triggers release of biomolecules, nanoparticles
3. Case and Cleveland Clinic researchers identify molecule in age-related macular degeneration
4. Researchers find molecule that may hold key to learning and memory
5. UCSF research pinpoints brain molecules role in developing addiction
6. Study identifies molecule essential for proper localization of blood stem cells
7. Research clarifies how brain replenishes memory-making molecules
8. Cellular molecule spurs growth of prostate cancer
9. Study broadens understanding of enzymes linked to tumor promoting molecule
10. Notch signaling molecule important in type 2 immunity
11. Researchers develop new concept for single molecule transistor

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hybrid molecule causes cancer cells self destruct

(Date:5/30/2015)... iconic American actor, and host of “In America” James ... Medical Malpractice. This segment of “In America” will cover ... field. , According to the Bureau of Justice Statistics, ... roughly only 20% of them made it to court, ... remaining 30% were tossed out. (Source: http://www.bjs.gov/index.cfm?ty=tp&tid=4511 ) ...
(Date:5/30/2015)... 30, 2015 A live auction will ... equipment from hospitals, surgery centers and other medical facilities ... be sold including radiology, surgery, endoscopy, lab, anesthesia, exam ... take place Tuesday, June 2nd starting at 10:00am EDT. ... at 5025 North Hiatus Rd., Sunrise, FL 33351. ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new ... hanging signs ; making what was formerly an elite ... rigging points at a usual height of 16’-20’ are easily ... signs are very unique and more visible than the largest ... dismantle labor and rigging the costs far outweigh the benefit ...
(Date:5/29/2015)... Ready to hit the road? Before embarking on ... get their vehicles ready. With handicapped vehicles, there are even ... (ADS) is ready to help drivers get their handicapped vans ... trips. , When planning for the big trip, drivers should ... trip goes smoothly and they are prepared for all contingencies: ...
(Date:5/29/2015)... PA (PRWEB) May 29, 2015 M3 ... quiz-based learning in 14 medical specialties, now offers ... a wide spectrum of rheumatology disorders ranging from Fibromyalgia ... Saint Jacques, editorial director of MDLinx, and Caroline Tredway, ... about the impact it will have on the physicians ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:MDLinx Launches Smartest Rheumatologist 2
(Date:5/29/2015)... N.J. , May 29, 2015  Fair Rate ... that a state-court jury in Delaware ... Fit inserts, designed to treat pelvic organ prolapse (POP) ... designed and that company executives hid the design flaws ... Logo - http://photos.prnewswire.com/prnh/20150529/219354LOGO Transvaginal ...
(Date:5/29/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... Conference on Tuesday, June 9, 2015. Jeffrey Simmons ... will participate in a fireside chat at 2:20 p.m., ... webcast will be available on the "Webcasts & Presentations" ... A replay of the fireside chat will be available ...
(Date:5/29/2015)... SAN DIEGO and BOSTON ... a leader in instrument development, custom automation, and contract ... developer of the Nanopatch™ needle-free drug delivery technology, have ... for development of the Nanopatch Jet Coating Instrument ... drug delivery research and product development.  The award was ...
Breaking Medicine Technology:TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3Lilly to Participate in Goldman Sachs Global Healthcare Conference 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3
Cached News: